Advertisement

Index by author

October 01, 2019; Volume 371,Issue 1

  1. Bullock, Kristin M.

    1. Modest Blood-Brain Barrier Permeability of the Cyclodextrin Kleptose: Modification by Efflux and Luminal Surface Binding
      W.A. Banks, Kory Engelke, Kim M. Hansen, Kristin M. Bullock and Pericles Calias
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 121-129; DOI: https://doi.org/10.1124/jpet.119.260497

  2. Burton, Michael D.

    1. Open Access
      Indirect AMP-Activated Protein Kinase Activators Prevent Incision-Induced Hyperalgesia and Block Hyperalgesic Priming, Whereas Positive Allosteric Modulators Block Only Priming in Mice
      Kufreobong E. Inyang, Michael D. Burton, Thomas Szabo-Pardi, Emma Wentworth, Timothy A. McDougal, Eric D. Ramirez, Grishma Pradhan, Gregory Dussor and Theodore J. Price
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 138-150; DOI: https://doi.org/10.1124/jpet.119.258400

  3. Calias, Pericles

    1. Modest Blood-Brain Barrier Permeability of the Cyclodextrin Kleptose: Modification by Efflux and Luminal Surface Binding
      W.A. Banks, Kory Engelke, Kim M. Hansen, Kristin M. Bullock and Pericles Calias
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 121-129; DOI: https://doi.org/10.1124/jpet.119.260497

  4. Campbell, John E.

    1. Open Access
      SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action
      Nina Dedic, Philip G. Jones, Seth C. Hopkins, Robert Lew, Liming Shao, John E. Campbell, Kerry L. Spear, Thomas H. Large, Una C. Campbell, Taleen Hanania, Emer Leahy and Kenneth S. Koblan
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 1-14; DOI: https://doi.org/10.1124/jpet.119.260281

  5. Campbell, Una C.

    1. Open Access
      SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action
      Nina Dedic, Philip G. Jones, Seth C. Hopkins, Robert Lew, Liming Shao, John E. Campbell, Kerry L. Spear, Thomas H. Large, Una C. Campbell, Taleen Hanania, Emer Leahy and Kenneth S. Koblan
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 1-14; DOI: https://doi.org/10.1124/jpet.119.260281

  6. Carracedo, Gonzalo

    1. Effect of Melatonin and Its Analogs on Tear Secretion
      Francisco Javier Navarro Gil, Fernando Huete-Toral, Almudena Crooke, Carmen Olalla Dominguez Godinez, Gonzalo Carracedo and Jesús Pintor
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 186-190; DOI: https://doi.org/10.1124/jpet.119.259192

  7. Carrillo-sepulveda, Maria Alicia

    1. Triiodothyronine Reduces Vascular Dysfunction Associated with Hypertension by Attenuating Protein Kinase G/Vasodilator-Stimulated Phosphoprotein Signaling
      Maria Alicia Carrillo-Sepulveda, Anjali Panackal, Renjith Maracheril, Nicole Maddie, Mitul N. Patel, Kaie Ojamaa, Olga V. Savinova and A. Martin Gerdes
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 88-94; DOI: https://doi.org/10.1124/jpet.119.260471

  8. Chen, Shiyan

    1. In Vitro and In Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues
      Shiyan Chen, Karl Austin-Muttitt, Linghua Harris Zhang, Jonathan G. L. Mullins and Aik Jiang Lau
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 75-86; DOI: https://doi.org/10.1124/jpet.119.259267

  9. Chikamatsu, Noriko

    1. Open Access
      Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor
      Tetsuya Taniguchi, Naoki Ashizawa, Koji Matsumoto, Ryo Saito, Keisuke Motoki, Miku Sakai, Noriko Chikamatsu, Chiharu Hagihara, Masamichi Hashiba and Takashi Iwanaga
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 162-170; DOI: https://doi.org/10.1124/jpet.119.259341

  10. Chinn, Leslie W.

    1. Open Access
      Absence of Pharmacokinetic Interactions between the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate
      Nicholas Steven Jones, Helen Winter, Tamiko R. Katsumoto, Marilyn Florero, Elaine Murray, Helen Walker, Nand Singh and Leslie W. Chinn
      Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 202-207; DOI: https://doi.org/10.1124/jpet.119.257089
« Previous (Pages : 1 2 3 4 5 6 7 8 ... 19) Next »
Back to top

In this issue

Advertisement